322 related articles for article (PubMed ID: 25233380)
1. Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection.
Sukumar N; Tan S; Aldridge BB; Russell DG
PLoS Pathog; 2014 Sep; 10(9):e1004394. PubMed ID: 25233380
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination.
Chuang YM; Dutta NK; Gordy JT; Campodónico VL; Pinn ML; Markham RB; Hung CF; Karakousis PC
Front Immunol; 2020; 11():680. PubMed ID: 32411131
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the Effect of Vaccination on Host-Pathogen Interactions in a Murine Model of Pulmonary Tuberculosis by
Zatarain-Barrón ZL; Ramos-Espinosa O; Marquina-Castillo B; Barrios-Payán J; Cornejo-Granados F; Maya-Lucas O; López-Leal G; Molina-Romero C; Anthony RM; Ochoa-Leyva A; De La Rosa-Velázquez IA; Rebollar-Vega RG; Warren RM; Mata-Espinosa DA; Hernández-Pando R; van Soolingen D
Front Immunol; 2020; 11():930. PubMed ID: 32508826
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies.
Zhang N; Strydom N; Tyagi S; Soni H; Tasneen R; Nuermberger EL; Savic RM
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907182
[TBL] [Abstract][Full Text] [Related]
5.
Clemmensen HS; Dube JY; McIntosh F; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Behr MA; Mortensen R
mBio; 2021 Apr; 12(2):. PubMed ID: 33879592
[TBL] [Abstract][Full Text] [Related]
6. Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development.
Chae H; Shin SJ
J Microbiol; 2018 May; 56(5):300-311. PubMed ID: 29721826
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
[TBL] [Abstract][Full Text] [Related]
8. Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo.
Liu Y; Tan S; Huang L; Abramovitch RB; Rohde KH; Zimmerman MD; Chen C; Dartois V; VanderVen BC; Russell DG
J Exp Med; 2016 May; 213(5):809-25. PubMed ID: 27114608
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis vaccine research: the impact of immunology.
Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis responds to chloride and pH as synergistic cues to the immune status of its host cell.
Tan S; Sukumar N; Abramovitch RB; Parish T; Russell DG
PLoS Pathog; 2013; 9(4):e1003282. PubMed ID: 23592993
[TBL] [Abstract][Full Text] [Related]
11. TB drug development: immunology at the table.
Nathan C; Barry CE
Immunol Rev; 2015 Mar; 264(1):308-18. PubMed ID: 25703568
[TBL] [Abstract][Full Text] [Related]
12. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
[TBL] [Abstract][Full Text] [Related]
13. Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability.
Ribechini E; Eckert I; Beilhack A; Du Plessis N; Walzl G; Schleicher U; Ritter U; Lutz MB
JCI Insight; 2019 Jun; 5(13):. PubMed ID: 31162143
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.
Coler RN; Bertholet S; Pine SO; Orr MT; Reese V; Windish HP; Davis C; Kahn M; Baldwin SL; Reed SG
J Infect Dis; 2013 Apr; 207(8):1242-52. PubMed ID: 22891286
[TBL] [Abstract][Full Text] [Related]
15. Trans-species communication in the Mycobacterium tuberculosis-infected macrophage.
Tan S; Russell DG
Immunol Rev; 2015 Mar; 264(1):233-48. PubMed ID: 25703563
[TBL] [Abstract][Full Text] [Related]
16. Natural and trained innate immunity against Mycobacterium tuberculosis.
Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
[TBL] [Abstract][Full Text] [Related]
17. HspX vaccination and role in virulence in the guinea pig model of tuberculosis.
Wieczorek AE; Troudt JL; Knabenbauer P; Taylor J; Pavlicek RL; Karls R; Hess A; Davidson RM; Strong M; Bielefeldt-Ohmann H; Izzo AA; Dobos KM
Pathog Dis; 2014 Aug; 71(3):315-25. PubMed ID: 24616427
[TBL] [Abstract][Full Text] [Related]
18. The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection.
Marimani M; Ahmad A; Duse A
Tuberculosis (Edinb); 2018 Dec; 113():200-214. PubMed ID: 30514504
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Fatty Acid Oxidation Promotes Macrophage Control of Mycobacterium tuberculosis.
Chandra P; He L; Zimmerman M; Yang G; Köster S; Ouimet M; Wang H; Moore KJ; Dartois V; Schilling JD; Philips JA
mBio; 2020 Jul; 11(4):. PubMed ID: 32636249
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice.
Koo MS; Manca C; Yang G; O'Brien P; Sung N; Tsenova L; Subbian S; Fallows D; Muller G; Ehrt S; Kaplan G
PLoS One; 2011 Feb; 6(2):e17091. PubMed ID: 21364878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
